Lidocaine 01
Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-2066
5 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-2066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lidocaine 02
Chemical structure diagram of Lidocaine Hydrochloride, showing its molecular arrangement with labeled atoms including the aromatic ring, amide group, and hydrochloride component.*
Lidocaine 03
Lidocaine 04
Label for Lidocaine Hydrochloride 2% Injection, USP 100 mg/5 mL (20 mg/mL), preservative-free single-dose vial. The solution is indicated for infiltration and nerve block including epidural and caudal routes. Distributed by Hospira, Inc., Lake Forest, IL. The label includes dosage and storage information with an NDC of 0409-2066-10.*
Lidocaine 05
Packaging label for Lidocaine Hydrochloride 2% Injection, USP, 100 mg/5 mL (20 mg/mL) preservative-free solution. The package contains 10 single-dose 5 mL vials. Labeled for infiltration and nerve block including epidural and caudal use. Distributed by Hospira, Inc., with NDC 0409-2066-05, made in Spain.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
